Skip to main content
NCBI home page
Springer logoLink to Springer
. 2025 Nov 25;26(1):47. doi: 10.1007/s10238-025-01981-9

Correction: Multidimensional analysis reveals the potential of ACSL3 as a cancer biomarker: from pan-cancer exploration to functional validation in hepatocellular carcinoma

Qun Niu 1,2, Yu Mou 1,2, Yuanqian Yao 1,2, HaiJian Dong 1,2, Kaixin Wang 1,2, Zijian Zeng 1,2, Yujing Tao 1,2, Xueqing Gong 1,2, Hui Li 1,2,✉
PMCID: PMC12644113  PMID: 41286385

Correction: Clinical and Experimental Medicine (2025) 25:351

https://doi.org/10.1007/s10238-025-01882-x

In the original version of the article, the affiliation details for the authors.

Qun Niu, Yu Mou, Yuanqian Yao, HaiJian Dong, Kaixin Wang, Zijian Zeng, Yujing Tao, Xueqing Gong.

were incorrectly given as.

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610,072, China.

Hui Li.

School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610,075, China.

but should have been.

Qun Niu, Yu Mou, Yuanqian Yao, HaiJian Dong, Kaixin Wang, Zijian Zeng, Yujing Tao, Xueqing Gong and Hui Li.

Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610,072, China.

School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610,075, China.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Clinical and Experimental Medicine are provided here courtesy of Springer

RESOURCES